Jessica Scott

Jessica Scott
Jessica Scott, M.D., J.D., Head of the R&D Patient Engagement Office at Takeda, leads the organization from vision to culture change, from developing medicines for patients to developing medicines with patients. Jessica and her team have embedded patient engagement into the structure of R&D. Working closely with researchers and study teams in Neuroscience, Gastroenterology, Oncology and Rare Diseases on a global level, they bring the perspective of patients living with conditions in these disease areas to Takeda to partner in the development of new medicines. Jessica launched an innovative internal video series, News Updates, to provide the global organization with …
Jessica Scott, M.D., J.D., Head of the R&D Patient Engagement Office at Takeda, leads the organization from vision to culture change, from developing medicines for patients to developing medicines with patients. Jessica and her team have embedded patient engagement into the structure of R&D. Working closely with researchers and study teams in Neuroscience, Gastroenterology, Oncology and Rare Diseases on a global level, they bring the perspective of patients living with conditions in these disease areas to Takeda to partner in the development of new medicines. Jessica launched an innovative internal video series, News Updates, to provide the global organization with focused and highly engaging synopses of key learnings from Patient Engagement activities and their impact new medicine development at Takeda. Jessica also creates strong enterprise-wide collaborations including with Patient Advocacy and Patient Recruitment & Retention functions to drive strong partnerships with patient and patient organization in drug development and evidence generation.
Jessica’s background as a lawyer and physician brings a unique combination of medical and legal process to Takeda. She employs disruptive and innovative thinking in rapidly changing environments to improve the lives of patients. Jessica has a proven track record of demonstrated leadership across industries including pharmaceutical, legal and healthcare.

Prior to joining Takeda, Jessica led the GlaxoSmithKline North America Medical Policy and Advocacy function within the Office of the Chief Medical Officer. She led efforts, both internally and externally, related to clinical trial transparency, data sharing, and patient-centricity, working collaboratively as an ambassador of GSK on global multi-stakeholder consortia Initiatives included developing an industry approach to sharing individual results with study participants, optimizing the clinical trial experience and developing the Science of Patient Input. Before to joining GSK, Jessica pioneered the development and implementation of an innovative program for improving patient outcomes through early dispute resolution, as Director of Healthcare ADR Innovation at Carolina Dispute Settlement Services, In healthcare, Jessica worked with hospital system executives across the United States and as well as with other high risk industries to improve safety and improve outcomes using a unique combination of human factors, systems engineering and law.

Jessica received her M.D. from Tufts University School of Medicine and completed her residency in Family Medicine at the University of Virginia. She practiced Family Medicine in North Carolina for more than a decade. Jessica also attended Campbell University School of Law, graduating with honors where she is currently licensed to practice law. She is also a certified mediator and is trained as a collaborative law attorney. Jessica has served on the NC Bar Association Health Law Section Council and the Ethics Committee.
See more

Articles: Jessica Scott

Understanding the Value of Patient Engagement

Opinion / Jessica Scott, Takeda’s head of R&D patient engagement, highlights how a better understanding of the value of patient engagement across the healthcare stakeholder spectrum will drive better health outcomes and why keeping an open and curious mindset is crucial in this endeavour.   By incorporating Patient Engagement (PE) into the process of drug development by…

Forging Connections & Trust – At A Safe Social Distance

Coronavirus / Takeda’s Head of R&D Patient Engagement Jessica Scott examines the parallels between partnering with patients and working remotely with colleagues in the time of COVID-19.   Patients need us to engage with them, ask questions and listen. Just as we’re experiencing now with our own work relationships with colleagues, deeper connections build trust, which in…

Bringing Patient Experience to Regulatory Decision-Making: Communication Pathway Needed

USA / Takeda’s Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug development and the regulatory decision-making process in the USA; as well as what more needs to be done in this crucial area.   Steps Taken by FDA Under the Food and Drug Administration Safety and Innovation Act[1] (FDASIA),…

See more